ICD-10 Coding for Choroidal Neovascularization(H35.05C, H35.32, H35.3211)
Comprehensive guide on ICD-10 coding for choroidal neovascularization, including documentation requirements, common pitfalls, and billing considerations.
Complete code families applicable to Choroidal Neovascularization
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| H35.3211 | Exudative age-related macular degeneration, right eye, active | Use when CNV is active in the right eye due to AMD. |
|
| H44.2A1 | Degenerative myopia with choroidal neovascularization, right eye | Use when CNV is secondary to degenerative myopia. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutChoroidal Neovascularization
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Choroidal Neovascularization.
Omitting CNV activity status
Impact
Clinical: Impacts treatment decisions., Regulatory: Leads to coding inaccuracies., Financial: Potential claim denials.
Mitigation
Always document imaging findings., Use templates to ensure completeness.
Incorrect laterality coding
Impact
Reimbursement: Claims may be denied or delayed., Compliance: Non-compliance with coding standards., Data Quality: Inaccurate patient records.
Mitigation
Verify and document the correct eye affected by CNV.
Incorrect use of laterality
Impact
Claims with incorrect laterality are frequently audited.
Mitigation
Double-check documentation and coding for laterality.